An RNA-sequencing (RNA-seq) analysis indicated that although all the PRMT family members were detectable in cancers, five PRMTs (PRMT1/2/4/5/7) exhibited remarkably high expression levels (average FPKM >10, Figure 2A, Figure S2A and Table S3). The gene discussed is PRMT1; the disease is cancer.